Clinical trial
Comparison of Clinical Performance and Hemocompatibility of Dialyzers Applied During Post-dilution Online Hemodiafiltration - eMPORA III Study (Modified POlysulfone membRAne)
NCT04714281 is registered in ClinicalTrials.gov with Fresenius Medical Care Deutschland GmbH as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Clinical Performance and Hemocompatibility of Dialyzers Applied During Post-dilution Online Hemodiafiltration - eMPORA III Study (Modified POlysulfone membRAne)
- Lead sponsor
- Fresenius Medical Care Deutschland GmbH
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 3, 2021
- Completion date
- May 5, 2023
- Enrollment
- 82 (actual)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.
end stage renal disease, renal failure